ERP29 and breast carcinoma: Similarly, Zhang et al. mentioned that the doxorubicin resistance in the MCF-7 breast cancer cell line was reversed after the knockdown of endoplasmic reticulum protein 29 (ERp29), a reticuloplasmin involved in endoplasmic reticulum proteostasis and protein excretion.